|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 14/605 | (2006.01) |
| (11) | Number of the document | 3057983 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14793463.2 |
| Date of filing the European patent application | 2014-10-17 | |
| (97) | Date of publication of the European application | 2016-08-24 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-13 |
| (46) | Date of publication of the claims translation | 2020-02-25 |
| (86) | Number | PCT/EP2014/072294 |
| Date | 2014-10-17 |
| (87) | Number | WO 2015/055802 |
| Date | 2015-04-23 |
| (30) | Number | Date | Country code |
| 201361892250 P | 2013-10-17 | US |
| (72) |
RIBER, Ditte, DK
TOLBORG, Jakob Lind, DK
HAMPRECHT, Dieter Wolfgang, DE
|
| (73) |
Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
Zealand Pharma A/S, Sydmarken 11, 2860 S borg, DK |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Gliukagono analogai |
| GLUCAGON ANALOGUES |
| Payment date | Validity (years) | Amount | |
| 2025-09-19 | 12 | 289.00 EUR |
| 2026-10-17 |